Sharpe-Strumia Research Foundation   Report issue

Foundation Phase 1 Phase 4
Founded: Bryn Mawr PA United States (2003)

Organization Overview

First Clinical Trial
2006
NCT00216788
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Sharpe-Strumia Research Foundation